Procalcitonin in Hepatocellular Carcinoma
NCT01518829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2013-10-01
Summary
the value of serum procalcitonin in differentiation between bacterial infection and non infectious inflammation in febrile HCC patients following locoeregional treatment for HCC.
Conditions
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Principal Investigators
-
Hisham K Dabbous, professor · Tropical medicine department
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2012-12-31
- Completion
- 2013-01-31
Countries
- Egypt
Study Locations
More Related Trials
-
Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
NCT01815489 ·Status: COMPLETED
-
Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)
NCT00866957 ·Status: COMPLETED
-
A New Prognostic Scoring System for Spontaneous Ruptured Hepatocellular
NCT03504358 ·Status: COMPLETED
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
NCT03804593 ·Status: COMPLETED
-
Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits
NCT01937286 ·Status: COMPLETED
-
Study of Hepatocellular Carcinoma in Cirrhotic Patients
NCT01904942 ·Status: COMPLETED
-
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
NCT03109457 ·Status: COMPLETED
-
Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma
NCT05327907 ·Status: UNKNOWN
-
The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC
NCT03722628 ·Status: UNKNOWN
-
Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection
NCT05105828 ·Status: COMPLETED
-
Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
NCT01963949 ·Status: WITHDRAWN
-
Hepatocellular Cancer (HCC) Screening in Zhongshan City
NCT02501980 ·Status: UNKNOWN
-
The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma
NCT03793322 ·Status: UNKNOWN ·Phase: PHASE1
-
Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation
NCT06960031 ·Status: COMPLETED
-
Pulmonary Function Tests Study in Cirrhotic Patients With and Without Hepatocellular Carcinoma
NCT05963776 ·Status: UNKNOWN
-
Management of Spontaneous Ruptured Hepatocellular Carcinoma
NCT03516890 ·Status: COMPLETED
-
Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas
NCT02682394 ·Status: UNKNOWN
-
Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test
NCT03493763 ·Status: UNKNOWN
-
ALBI and PALBI Scores and HCC Prognosis
NCT05720195 ·Status: COMPLETED
-
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .
NCT06168357 ·Status: NOT_YET_RECRUITING
-
Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma
NCT00842647 ·Status: UNKNOWN
-
Long-term Management of Patients With Ruptured HCC
NCT06505291 ·Status: COMPLETED
-
68Ga-FAPI PET/CT in Liver Fibrosis Patients
NCT04533828 ·Status: UNKNOWN ·Phase: EARLY_PHASE1